Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report Article

Singh, Purnima, Wang, Xuexia, Hageman, Lindsey et al. (2020). Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report . CANCER, 126(17), 4051-4058. 10.1002/cncr.32948

Open Access

cited authors

  • Singh, Purnima; Wang, Xuexia; Hageman, Lindsey; Chen, Yanjun; Magdy, Tarek; Landier, Wendy; Ginsberg, Jill P; Neglia, Joseph P; Sklar, Charles A; Castellino, Sharon M; Dreyer, Zoann E; Hudson, Melissa M; Robison, Leslie L; Blanco, Javier G; Relling, Mary; Burridge, Paul; Bhatia, Smita

sustainable development goals

authors

publication date

  • September 1, 2020

published in

keywords

  • CONGESTIVE-HEART-FAILURE
  • DOXORUBICIN
  • GENETIC POLYMORPHISMS
  • INDUCED CARDIOTOXICITY
  • LEUKEMIA
  • Life Sciences & Biomedicine
  • MORTALITY
  • OUTCOMES
  • Oncology
  • RETROSPECTIVE ANALYSIS
  • SURVIVORS
  • SUSCEPTIBILITY
  • Science & Technology
  • anthracyclines
  • cardiomyopathy
  • childhood cancer survivors
  • gene expression
  • glutathione S-transferase 1 (GSTM1) null genotype

Digital Object Identifier (DOI)

publisher

  • WILEY

start page

  • 4051

end page

  • 4058

volume

  • 126

issue

  • 17